Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-25 @ 4:15 AM
Ignite Modification Date: 2025-12-26 @ 3:14 AM
NCT ID: NCT00703820
Term: Allergic reaction/hypersensitivity (including drug fever)
Organ System: Immune system disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: CTCAE v. 3.0
Notes: None
Study: NCT00703820
Study Brief: Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 11 9 133 View
EG001 10 9 129 View
EG002 0 0 29 View